Search Results | OpenEmory

Start Over Keyword MCL-1

<span itemprop="name">Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors</span>

$<span itemprop="name">Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma</span>$

<span itemprop="name">Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine</span>

<span itemprop="name">Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting</span>

<span itemprop="name">The novel BET degrader, QCA570, is highly active against the growth of human NSCLC cells and synergizes with osimertinib in suppressing osimertinib-resistant EGFR-mutant NSCLC cells</span>

<span itemprop="name">ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib</span>

$<span itemprop="name">A Phase 1 Dose-Escalation Study of Filanesib Plus Bortezomib and Dexamethasone in Patients With Recurrent/ Refractory Multiple Myeloma</span>$

<span itemprop="name">Novel Small-Molecule Inhibitors of Bcl-XL to Treat Lung Cancer</span>

$<span itemprop="name">A Phase 1 and 2 Study of Filanesib Alone and in Combination With Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma</span>$

<span itemprop="name">Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax</span>

« Previous
Next »
1 Current Page, Page 1
2